Acea Biosciences Agilent to Acquire BioTek Instruments for $1.17B Vermont-based BioTek is a privately held company that manufactures and sells life science instruments, including cell imaging systems. Agilent to Acquire ACEA Biosciences ACEA's xCELLigence impedance-based, label-free, real-time cell analysis instruments are used in immuno-oncology pre-clinical drug discovery and development. IP Roundup: Jan 25, 2011 Premium Yale University, University of South Florida, Alabama State University, Stanford University, SRU Biosystems, Eppendorf Array Technology, Agilent Technologies, Acea Biosciences Acea, Vivo Biosciences Partner to Develop Assays for Roche's xCelligence System The new label-free and real-time cell-based assays will incorporate Vivo's HuBiogel platform. Cellular Dynamics, Roche, Acea Partner on Cardiotoxic Prediction Research The firms are developing a system for the early and accurate prediction of cardiotoxic side effects in the drug discovery process. Mar 20, 2009 EPA Presents Phase I ToxCast Data for First Time, Extends Acea's Participation for One Year Premium Breaking News Imaging Mass Cytometry Discovers Tumor Microenvironment Features Predicting Lung Cancer Outcomes Metastatic Tumor Subtypes Found With Expression Profiling GenomeWeb Top 40 up 4 Percent in January, Following Broader Upswing LumiraDx Receives Notice From Nasdaq Over Missed Listing Requirement Sherlock Biosciences to Acquire Sense Biodetection The Scan Study Links Evolution of Longevity, Social Organization in Mammals With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals. Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival. CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system. Drug Response Variants May Be Distinct in Somatic, Germline Samples Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.